Scientists from the Morgridge Institute for Research, the University of Wisconsin–Madison, the University of California and the WiCell Research Institute moved gene therapy one step closer to clinical reality by determining that the process of correcting a genetic defect does not substantially increase the number of potentially cancer-causing mutations in induced pluripotent stem cells.
Category: Regenerative Biology
Wisconsin, Morgridge scientists excise vector, exotic genes from induced stem cells
A team of scientists from the Morgridge Institute for Research at the University of Wisconsin–Madison reports that it has created induced human pluripotent stem (iPS) cells completely free of viral vectors and exotic genes.
Stem cell pioneer James Thomson to steer regenerative medicine at MIR
The Morgridge Institute for Research, the private, not-for-profit side of the Wisconsin Institutes for Discovery, is announcing the appointment of world-renowned stem cell pioneer and researcher James Thomson as the first member of its multidisciplinary scientific leadership team.
